SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-151023
Filing Date
2013-04-11
Accepted
2013-04-11 16:10:58
Documents
3
Period of Report
2013-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d520398d8k.htm 8-K 18030
2 PRESS RELEASE d520398dex991.htm EX-99.1 14499
3 GRAPHIC g520398g93z61.jpg GRAPHIC 2922
  Complete submission text file 0001193125-13-151023.txt   38116
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 13756386
SIC: 2834 Pharmaceutical Preparations